Current Report Filing (8-k)
February 03 2021 - 4:21PM
Edgar (US Regulatory)
0001069183false00010691832021-01-292021-01-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
January 29, 2021
Date of Report (Date of earliest event reported)
Axon Enterprise, Inc.
(Exact name of registrant as specified in charter)
|
|
|
Delaware
|
001-16391
|
86-0741227
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
17800 N. 85th St.
Scottsdale, Arizona 85255
(Address of principal executive offices, including zip code)
(480) 991-0797
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.00001 Par Value
|
AXON
|
The Nasdaq Global Select Market
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement
On January 29, 2021, Axon Enterprise, Inc. (the "Company" or "Axon"), entered into an Amendment to its Amended and Restated Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A. The amendment, which was effective January 25, 2021, extends the term of the Credit Agreement from December 31, 2021 to December 31, 2023 and increases the amount of the unsecured revolving line of credit which is available for letters of credit from $10 million to $20 million. The amendment also updates the amounts or terms of certain of the affirmative and negative covenants, and identifies certain events related to the anticipated cessation of the London Inter-Bank Offered Rate that would result in the selection of an alternate rate of interest.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
Dated: February 3, 2021
|
Axon Enterprise, Inc.
|
|
|
|
|
|
|
By:
|
/s/ JAWAD A. AHSAN
|
|
|
|
Jawad A. Ahsan
|
|
|
|
Chief Financial Officer
|
|
Axon Enterprise (NASDAQ:AAXN)
Historical Stock Chart
From Apr 2024 to May 2024
Axon Enterprise (NASDAQ:AAXN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Axon Enterprise Inc (NASDAQ): 0 recent articles
More Axon Enterprise, Inc. News Articles